Hims & Hers Health (NYSE:HIMS) Lowered to “Underperform” Rating by Bank of America

Bank of America downgraded shares of Hims & Hers Health (NYSE:HIMS – Free Report) from a buy rating to an underperform rating in a report issued on Thursday, Marketbeat.com reports. A number of other research firms have also weighed in on HIMS. TD Cowen raised their price target on shares of Hims & Hers Health […]

Leave a Reply

Your email address will not be published.

Previous post Morgan Stanley Forecasts Strong Price Appreciation for Smurfit Westrock (NYSE:SW) Stock
Next post Bristol-Myers Squibb (NYSE:BMY) Price Target Raised to $60.00